insights_auto
Why is TGTX down 2.16%?
Dive Deeperchevron_right
TGTX:NASDAQ
TG Therapeutics Inc common stock
$56.19
arrow_downward
-2.16%(-1.24) 1D
$56.30
arrow_upward
+0.20% (+0.11)todayPre-market
Closed: Sep 28, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TGTX...
Open
$57.35
High
$57.66
Low
$55.88
Mkt. cap
8.60B
Avg. vol.
1.89M
Volume
3.40K
P/E ratio
20.47
52-wk high
$59.30
52-wk low
$26.76
EPS
$2.75
Beta
1.67
Shares outstanding
153.07M
No. of employees
399
Open
$57.35
High
$57.66
Low
$55.88
Mkt. cap
8.60B
Avg. vol.
1.89M
Volume
3.40K
P/E ratio
20.47
52-wk high
$59.30
52-wk low
$26.76
EPS
$2.75
Beta
1.67
Shares outstanding
153.07M
No. of employees
399
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 month ago
TGTX Q2 2026 Earnings: EPS of $0.05 Misses Estimates by 85.5%, Shares Fall 2.79% - Long-Term Guidance
https://www.dars.gov.et/
·
1 month ago
TGTX Q1 2026 Earnings: EPS Falls 40% Short of Estimates, Stock Slips 2.8% - Adjusted Earnings Analysis
About TG Therapeutics Inc common stock
CEOMichael S Weiss
Employees399
Founded1993
HeadquartersMorrisville, North Carolina, United States
SectorBiotechnology
Websitetgtherapeutics.com